CND 2023
In March 2023, as part of the 66th Session of the UN Commission on Narcotic Drugs, Prekursor Foundation participated in a side-event co-organised by the Eurasian Harm Reduction Association, the Ukrainian Network of People who Use Drugs (PUD.UA/VOLNA), the Alliance for Public Health and the Ministry of Health of Ukraine.
The session 'Drug-related health responses to the humanitarian crisis in Ukraine and neighbouring countries' focused on the assistance provided by the Prekursor to refugees who need access to treatment and harm reduction services in Poland.
5th European Harm Reduction Conference
In November 2021, the 5th European Harm Reduction Conference, co-organized by Correlation European Harm Reduction Network, Eurasian Harm Reduction Association and the Czech organization Sananim, took place in Prague. It is the largest and most important meeting of organizations, representatives of user communities, activists, professionals and researchers working in the field of harm reduction.
The participants discussed the latest developments in the field, innovations, good practices, drug policies and the possibility of integrating activities into a wider help system. Prekursor Foundation participated in a panel on monitoring and implementation of quality standards in harm reduction.
CND
The Commission on Narcotic Drugs is one of nine functional commissions within the Economic and Social Council structure. It is the central decision-making body of the United Nations in the field of drugs policy at the global level. It deals with all issues concerning illicit psychoactive substances (supply reduction as well as demand reduction). The Commission meets annually at the UN headquarters in Vienna.
In 2017, as part of the 60th Session of the Commission, the Prekursor Foundation co-organized two side-events:
• Comprehensive Community-based HIV, Hepatitis C and Tuberculosis Prevention (together with National Bureau for Drug Prevention and Fondazione Villa Maraini/Red Cross and Red Crescent Partnership on Substance Abuse)
• Do we need drug demand reduction standards? (together with National Bureau for Drug Prevention and European Monitoring Centre for Drugs and Drug Addiction)
• Comprehensive Community-based HIV, Hepatitis C and Tuberculosis Prevention (together with National Bureau for Drug Prevention and Fondazione Villa Maraini/Red Cross and Red Crescent Partnership on Substance Abuse)
• Do we need drug demand reduction standards? (together with National Bureau for Drug Prevention and European Monitoring Centre for Drugs and Drug Addiction)
ATOME
The Access To Opioid Medication in Europe (ATOME) project was initiated by the Access to Controlled Medications Programme of WHO. It was a five-year project funded under the 7th Framework Programme of the European Community [FP7/2007-2013] under grant agreement n° 222994. The project consortium consisted of partners from the field of law, public health, palliative care and harm reduction.
The project investigated why opioid medicines for moderate to severe pain and for the treatment of opioid dependence are not used adequately in twelve European countries, and developed tailor-made solutions for improved access to opioid medicines in these countries.
The Prekursor Foundation (still operating as the Harm Reduction Foundation at the time) was an organizer and participant in a symposium on opioid use in Poland held in Warsaw in April 2014.
